查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1514325

吸收性抗菌包膜市場：現況分析與預測（2024-2032）

Absorbable Antibacterial Envelope Market: Current Analysis and Forecast (2024-2032)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

吸收性抗菌包膜市場預計將呈現約 5% 的成長率。這主要是由於心血管疾病治療研究和開發的不斷改進正在推動市場需求。例如，2022 年4 月，Aziyo Biologics, Inc. 的CanGaroo RM 抗菌包膜獲得了美國食品和藥物管理局(FDA) 的510(k) 上市前批准，這是一種用於植入式電子設備( IED) 的下一代生物材料包膜。Aziyo Biologics 是一家商業階段的再生醫學公司，致力於透過開發獨特的產品來改善手術患者的治療效果，包括：

依類型劃分，市場分為心臟再同步治療去顫器 (CRT-D) 和植入式心律轉復除顫器 (ICD)。心臟再同步治療去顫器 (CRT-D) 類別預計將佔據可吸收抗菌包膜市場的最大市場佔有率，解決日益增長的設備相關感染問題。由於 CRT-D 用於患有嚴重心臟衰竭的患者，因此它們比 ICD 或標準起搏器更複雜且植入時間更長，並且需要採取特殊措施以避免感染。關於可吸收的抗菌包膜，這是為了降低裝置植入部位周圍可能的感染風險。CRT-D 設備的病人安全性的提高和效率的提高將促使這些設備的使用增加，從而增加對可吸收抗菌敷料的需求。這就是為什麼心臟設備和感染控制解決方案的需求相結合對於推動該領域的發展至關重要。

根據最終用戶，市場分為醫院、門診手術中心（ASC）等。其中，到 2023 年，醫院的價值將領先全球市場。這主要是因為醫院制定了患者護理標準，並鼓勵使用可吸收的抗菌敷料來預防心臟裝置植入物的感染。此外，醫院中植牙手術的數量不斷增加，以及對這些手術中更好的標準和品質的日益關注，進一步提高了這些信封的利用率。促進市場成長的另一個關鍵因素是醫院網路和集團採購組織採用標準化程序，在其附屬組織中使用供應商提供的吸收性抗菌敷料，實現規模經濟並擴大市場飽和度。

為了更瞭解吸收性抗菌信封的市場介紹，市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、英國、法國、西班牙、義大利、歐洲其他地區）、亞太地區（中國） 、日本）、印度、亞太地區其他地區）和世界其他地區。特別是，由於心血管疾病的高盛行率和心臟裝置植入物數量的增加，北美可吸收的抗菌包膜市場預計將顯著增長。該地區先進的醫療保健基礎設施，加上強有力的監管支持和高額醫療保健支出，正在推動可吸收抗菌繃帶等創新醫療解決方案的採用。此外，主要市場參與者的存在和持續的研發活動也有助於市場擴張。人們對醫療程序中感染預防重要性的認識不斷提高以及先進醫療技術的採用也推動了北美市場的發展。

目錄

第1章 市場介紹

  • 市場定義
  • 主要目標
  • 利益相關者
  • 限制

第2章 研究方法或前提條件

  • 調查過程
  • 調查方法
  • 受訪者簡介

第3章 執行摘要

  • 業界總結
  • 分部展望
    • 市場成長的力量
  • 區域展望

第四章市場動態

  • 促進因素
  • 機會
  • 抑制因素
  • 趨勢
  • PESTEL 分析
  • 需求面分析
  • 供給側分析
    • 併購
    • 產品上市及投資場景
    • 產業洞察：主要新創公司及其獨特策略

第5章 價格分析

  • 區域價格分析
  • 影響價格的因素

第六章全球吸收性抗菌信封市場收入，2022-2032

第七章 市場考量：依類型

  • 心臟再同步治療去顫器 (CRT-D)
  • 植入式心臟復律去顫器 (ICD)

第 8 章市場分析：依最終用戶

  • 醫院
  • 門診手術中心 (ASC)
  • 其他

第9章市場分析：依地區

  • 北美
    • 美國
    • 加拿大
    • 其他北美
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太其他地區
  • 其他地區

第10章價值鏈分析

  • 邊際分析
  • 進入市場的企業名單

第十一章競爭格局

  • 比賽儀表板
  • 競爭市場定位分析
  • 波特五力分析

第12章 公司簡介

  • Medtronic
    • Company Overview
    • Key Financials
    • SWOT Analysis
    • Product Portfolio
    • Recent Developments
  • Elutia

第13章 縮寫與先決條件

第14章 附錄

簡介目錄
Product Code: UMHE212870

The absorbable antibacterial envelope market concerns the manufacture and use of distinct, biodegradable pouches for containment of cardiovascular and other implantable devices, like pacemakers and defibrillators, which release antimicrobial substances to protect against infection. This market is influenced by several factors, such as a rising rate of cardiac ailments, innovations in biomedical equipment, and a heightened concern over hospital-acquired illnesses. For instance, it is estimated that a heart attack happens within every 40 seconds in the United States and each year, 805,000 people in the United States suffer a heart attack based on the CDC report updated in October 2022. An increasing incidence and implantation of cardiac devices, along with the need for new and effective anti-infective strategies in device use, offers market promotion. Also, the availability of favorable government policies, a rise in healthcare expenditure, and the use of advanced medical solutions in developing countries help to drive the solid growth of the market.

The market for absorbable antibacterial envelope market is set to exhibit a growth rate of about 5%. This is mainly due to the continuous improvements in research and development in the treatment of cardiovascular diseases driving the demand of the market. For instance, in April 2022, Aziyo Biologics, Inc. filed a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for CanGaroo RM antibacterial envelope, its next-generation biomaterial envelope for use with implantable electronic devices (IED). Aziyo Biologics is a commercial-stage regenerative medicine firm dedicated to developing the following line of distinctive products and enhancing surgical patient outcomes.

Based on type, the market is segmented into cardiac resynchronization therapy defibrillators (CRT-D) and implantable cardioverter defibrillators (ICD). The cardiac resynchronization therapy defibrillators (CRT-D) category is expected to have the largest market share of the absorbable antibacterial envelope market by addressing the rising concerns of device-related infections. CRT-D devices are used for patients with severe heart failure and hence, need some extra measures to avoid infections because of their complexity and longer implantation times than required for ICDs or standard pacemakers. As for the absorbable antibacterial envelopes, it is to reduce infection risks that may be around the area of implantation of the device. Improved patient safety and increased efficiency of the CRT-D devices lead to increased usage of these devices, hence the demand for absorbable antibacterial envelopes. That is the reason why the combination of cardiac devices with the need for infection control solutions is crucial in developmental progression within this sector.

Based on end-user, the market has been divided into hospitals, ambulatory surgical centers (ASCs), and others. Among them, the hospitals were leading the global market in terms of value in 2023. This is mainly because hospitals set standards for patient care, encouraging the use of absorbable antibacterial envelopes to prevent infections in cardiac device implantations. Furthermore, the increasing number of implant surgeries in hospitals, integrated with an increased focus on better standards and quality in these procedures, further the usage rate of these envelopes. Another important factor that contributes to the market growth is the role of hospital networks or group purchasing organizations as they adopt standardized procedures of using absorbable antibacterial envelopes provided by the vendors across their affiliated organizations, achieving economies of scale, and expanding the market saturation.

For a better understanding of the market adoption of absorbable antibacterial envelope, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. Among them, the North American absorbable antibacterial envelope market is poised for significant growth, driven by the high prevalence of cardiovascular diseases and the increasing number of cardiac device implantations. The region's advanced healthcare infrastructure, coupled with strong regulatory support and substantial healthcare spending, facilitates the adoption of innovative medical solutions like absorbable antibacterial envelopes. Additionally, the presence of major market players and ongoing research and development activities further contribute to market expansion. Rising awareness about the importance of infection prevention in medical procedures and the adoption of advanced healthcare technologies also propel the market forward in North America.

Some of the major players operating in the market include Medtronic and Elutia.

TABLE OF CONTENTS

1.MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2.RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Global Absorbable Antibacterial Envelope Market
  • 2.2. Research Methodology of the Global Absorbable Antibacterial Envelope Market
  • 2.3. Respondent Profile

3.EXECUTIVE SUMMARY

  • 3.1. Industry Synopsis
  • 3.2. Segmental Outlook
    • 3.2.1. Market Growth Intensity
  • 3.3. Regional Outlook

4.MARKET DYNAMICS

  • 4.1. Drivers
  • 4.2. Opportunity
  • 4.3. Restraints
  • 4.4. Trends
  • 4.5. PESTEL Analysis
  • 4.6. Demand Side Analysis
  • 4.7. Supply Side Analysis
    • 4.7.1. Merger & Acquisition
    • 4.7.2. Product Launch and Investment Scenario
    • 4.7.3. Industry Insights: Leading Startups and Their Unique Strategies

5.PRICING ANALYSIS

  • 5.1. Regional Pricing Analysis
  • 5.2. Price Influencing Factors

6.GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET REVENUE (USD MN), 2022-2032F

7.MARKET INSIGHTS BY TYPE

  • 7.1. Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • 7.2. Implantable Cardioverter Defibrillators (ICD)

8.MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Ambulatory Surgical Centers (ASCs)
  • 8.3. Others

9.MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10.VALUE CHAIN ANALYSIS

  • 10.1. Marginal Analysis
  • 10.2. List of Market Participants

11.COMPETITIVE LANDSCAPE

  • 11.1. Competition Dashboard
  • 11.2. Competitor Market Positioning Analysis
  • 11.3. Porter Five Forces Analysis

12.COMPANY PROFILED

  • 12.1. Medtronic
    • 12.1.1. Company Overview
    • 12.1.2. Key Financials
    • 12.1.3. SWOT Analysis
    • 12.1.4. Product Portfolio
    • 12.1.5. Recent Developments
  • 12.2. Elutia

13.ACRONYMS & ASSUMPTION

14.ANNEXURE